maintain hold despit valuat challeng
appear front
challeng fundament front-end retail pharmaci ex-u make own
maintain hold compani fundament across busi line
remain challeng us front-end rev remain pressur see
improv soon given pressur on-going effort reduc retail
sq ft pharmaci econom also pressur broader drug price trend come
uk oper drag macro factor
summari ep miss front-end ss rx compstore fall short
report ep street shortfal driven
weak front-end ss rev below-expect pharmaci ss rev
ly significantli expect
steep declin front-end compstore underscor fundament challeng face
write effort introduc privat label over-the-counter medic
health/wel product move impact front-end sale
retail pharmaci evidenc ss perform report
issu like get wors expand basic solimo product offer
also impact ss outlook move reduc front-end footprint make
room servic offerings/partnership lh kr well decis de-
weak pharmaci busi surpris expos drug price
soft rx busi surpris management admit volum
short expect call drug price headwind gener deflat
lower brand inflat driver weak surpris comment
gener proprietari work comment rx distributor suggest stabil
gener price brand rx management comment highlight immun
pressur brand drug price like rest rx suppli chain
unfortun headwind unlik abat drug remain polit scrutini
flat ep three year period make hard argu multipl expans nt
revis ep estim respect
line reflect challeng comment made call
consid ep boost signific share buyback earn outlook
highlight oper declin busi experienc make difficult
weak reduc abil aggress buy-back stock also concern
abil gener strong consist bright spot compani
weak concern addit view stock perform
quarter despit management repurchas
indic weak investor sentiment low interest stock fundament
weaken expect investor interest continu wane stock see downward
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
pressur especi management abil aggress repurchas share limit
increas balanc sheet leverag
pleas see import disclosur inform page report
although valu independ on-going
effort transit retail pharmaci box hc
services-orient busi believ recent fundament
soft make difficult refut concern risk
bring especi acquisit mail order
believ nt earn impact
acquisit pillpack like immateri percept
concern success integr pillpack
consum offer year like weigh
stock nt potenti impact actual earn
pharmaci gross margin continu declin
result on-going reimburs pressur
abl gain meaning sg leverag
transfer script store
front-end compstore pressur larg result
unlik abat nt
amzn acquisit pillpack immateri impact
ep overhang limit multipl expans
abl secur place central prefer
beauti differenti redesign privat label focu lift
gross margin higher expect boost front-end compstore
posit territori
pharmaci gross profit pressur subsid result
addit script volum new partnership
ep target multipl line w/ pre-amzn
abl win new prefer retail pharmaci
contract lose prefer part-d anchor pharmaci
posit competitor
beauti differenti redesign privat label focu isnt
abl produc higher front-end gross margin compstore
addit pressur over-the-counter private-label emerg
expand rx busi addit
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
